US Stock MarketDetailed Quotes
PRTG Portage Biotech
- 6.000
- +3.300+122.20%
Close Aug 23 16:00 ET
- 5.760
- -0.240-4.00%
Post 19:59 ET
6.29MMarket Cap-77P/E (TTM)
8.280High3.900Low49.67MVolume4.250Open2.700Pre Close317.21MTurnover8358.59%Turnover RatioLossP/E (Static)1.05MShares61.98852wk High1.56P/B3.57MFloat Cap2.08052wk Low--Dividend TTM594.23KShs Float899.526Historical High--Div YieldTTM162.20%Amplitude2.080Historical Low6.386Avg Price1Lot Size
Portage Biotech Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 10.12%18.25M | -20.02%3.26M | -15.13%4.04M | 62.74%5.95M | 22.53%5.01M | 6.34%16.58M | -9.34%4.08M | 14.18%4.76M | 9.70%3.65M | 13.75%4.09M |
| Selling and administrative expenses | -28.31%5.66M | -2.18%1.35M | -43.62%1.25M | -18.92%1.69M | -38.04%1.37M | -10.41%7.9M | -45.56%1.38M | -0.76%2.22M | 4.40%2.09M | 8.01%2.21M |
| -General and administrative expense | -28.31%5.66M | -2.18%1.35M | -43.62%1.25M | -18.92%1.69M | -38.04%1.37M | -10.41%7.9M | -45.56%1.38M | -0.76%2.22M | 4.40%2.09M | 8.01%2.21M |
| Research and development costs | 44.51%12.54M | -29.61%1.9M | 9.31%2.77M | 170.73%4.24M | 93.34%3.63M | 28.14%8.67M | 37.30%2.7M | 31.48%2.54M | 17.67%1.57M | 21.35%1.88M |
| Depreciation amortization depletion | 5,300.00%54K | --13K | 1,400.00%15K | --15K | --11K | --1K | --0 | --1K | --0 | --0 |
| -Depreciation and amortization | 5,300.00%54K | --13K | 1,400.00%15K | --15K | --11K | --1K | --0 | --1K | --0 | --0 |
| Operating profit | -10.12%-18.25M | 20.02%-3.26M | 15.13%-4.04M | -62.74%-5.95M | -22.53%-5.01M | -6.34%-16.58M | 9.34%-4.08M | -14.18%-4.76M | -9.70%-3.65M | -13.75%-4.09M |
| Net non-operating interest income expense | 16.35%242K | -48.04%53K | 32.00%66K | 22.86%43K | 280.95%80K | 583.72%208K | 10,300.00%102K | 5,100.00%50K | 600.00%35K | 161.76%21K |
| Non-operating interest income | 26.27%274K | -41.18%60K | 50.00%75K | 20.45%53K | 280.95%80K | --217K | --102K | --50K | --44K | --21K |
| Non-operating interest expense | 255.56%32K | --7K | --9K | 11.11%10K | ---- | -79.07%9K | --0 | --0 | 28.57%9K | ---- |
| Other net income (expense) | 36.02%-67.92M | 79.41%-21.71M | -7,484.63%-44.9M | -750.00%-170K | -929.73%-1.14M | -13,141.03%-106.15M | -23,477.16%-105.43M | -830.86%-592K | 53.49%-20K | -134.15%-111K |
| Gain on sale of security | 38,100.00%7.6M | 94,214.29%6.6M | 1,618.97%997K | 50.00%-17K | -2,043.14%-1.09M | -102.28%-20K | -95.33%7K | -83.04%58K | -326.67%-34K | -113.82%-51K |
| Earnings from equity interest | 10.38%-233K | -187.50%-7K | 10.53%-136K | 28.57%-40K | 16.67%-50K | -319.35%-260K | -97.34%8K | 41.76%-152K | 3.45%-56K | -36.36%-60K |
| Special income (charges) | 29.68%-74.45M | 73.59%-27.85M | -9,011.04%-45.37M | -261.43%-113K | ---- | ---105.87M | ---105.45M | ---498K | --70K | ---- |
| -Less：Restructuring and merger&acquisition | -317.00%-11.31M | -133.48%-7.33M | -1,144.18%-5.2M | 261.43%113K | ---- | ---2.71M | ---3.14M | --498K | ---70K | ---- |
| -Less:Impairment of capital assets | --0 | ---- | ---- | ---- | ---- | --43.86M | ---- | ---- | ---- | ---- |
| -Less:Other special charges | --3.09M | --0 | --3.09M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Write off | 27.75%82.69M | -45.61%35.21M | --47.48M | ---- | ---- | --64.72M | --64.72M | --0 | ---- | ---- |
| -Gain on sale of business | --27K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | ---839K | ---450K | ---389K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 29.87%-85.93M | 77.23%-24.91M | -821.82%-48.88M | -66.90%-6.07M | -45.34%-6.07M | -726.90%-122.52M | -2,604.03%-109.41M | -29.66%-5.3M | -7.63%-3.64M | -26.50%-4.18M |
| Income tax | 40.93%-10.55M | 100.01%1K | -531.88%-9.5M | 64.47%-907K | 94.32%-145K | -510.29%-17.86M | -410.36%-14.95M | 1,779.49%2.2M | -407.55%-2.55M | -3,130.38%-2.55M |
| Net income | 27.98%-75.38M | 73.62%-24.91M | -424.97%-39.38M | -376.04%-5.17M | -264.68%-5.93M | -446.02%-104.67M | -965.72%-94.46M | -78.34%-7.5M | 62.29%-1.09M | 49.58%-1.63M |
| Net income continuous Operations | 27.98%-75.38M | 73.62%-24.91M | -424.97%-39.38M | -376.04%-5.17M | -264.68%-5.93M | -446.02%-104.67M | -965.72%-94.46M | -78.34%-7.5M | 62.29%-1.09M | 49.58%-1.63M |
| Minority interest income | 21.82%-43K | -242.86%-24K | 68.75%-5K | 94.85%-7K | -106.73%-7K | 97.61%-55K | 99.55%-7K | 97.69%-16K | -238.78%-136K | 166.24%104K |
| Net income attributable to the parent company | 27.98%-75.34M | 73.65%-24.89M | -426.03%-39.37M | -443.52%-5.16M | -242.34%-5.92M | -520.10%-104.61M | -1,190.80%-94.45M | -113.13%-7.49M | 68.10%-949K | 43.61%-1.73M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 27.98%-75.34M | 73.65%-24.89M | -426.03%-39.37M | -443.52%-5.16M | -242.34%-5.92M | -520.10%-104.61M | -1,190.80%-94.45M | -113.13%-7.49M | 68.10%-949K | 43.61%-1.73M |
| Basic earnings per share | 40.06%-77.8 | 79.28%-24.2 | -327.27%-37.6 | -383.33%-5.8 | -153.85%-6.6 | -403.10%-129.8 | -961.82%-116.8 | -69.23%-8.8 | 72.73%-1.2 | 48.00%-2.6 |
| Diluted earnings per share | 40.06%-77.8 | 79.28%-24.2 | -327.27%-37.6 | -383.33%-5.8 | -153.85%-6.6 | -403.10%-129.8 | -961.82%-116.8 | -69.23%-8.8 | 72.73%-1.2 | 48.00%-2.6 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg